Table 2 Imunohistostaining of each biomarkers by site (n = 56)
Positive vascular invasion group | Negative vascular invasion group | Total | p valuea | |
|---|---|---|---|---|
Antibody | (n = 13) | (n = 43) | (n = 56) | |
Tumor site | ||||
Conventional DCP (MU-3) | 9 (69.2%) | 29 (67.4%) | 38 (67.9%) | 0.90 |
Next-generation DCP (P-16) | 11 (84.6%) | 34 (79.1%) | 45 (80.4%) | 0.66 |
Vascular invasion site | ||||
Conventional DCP (MU-3) | 2 (15.4%) | 0 (0%) | 2 (3.6%) | < 0.0001 |
Next-generation DCP (P-16) | 6 (46.2%) | 0 (0%) | 6 (10.7%) | 0.0008 |
Alpha-fetoprotein | 0 (0%) | 0 (0%) | 0 (0%) | 1.00 |